Detalhe da pesquisa
1.
Risk of Alzheimer's disease is associated with longitudinal changes in plasma biomarkers in the multi-ethnic Washington Heights-Hamilton Heights-Inwood Columbia Aging Project (WHICAP) cohort.
Alzheimers Dement
; 20(3): 1988-1999, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38183363
2.
ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium.
Alzheimers Dement
; 20(1): 549-562, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37740924
3.
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease.
Alzheimers Dement
; 20(4): 2698-2706, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400532
4.
Neurofilament light chain: A potential biomarker for cerebrovascular disease in children with sickle cell anaemia.
Br J Haematol
; 203(3): 460-467, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37581299
5.
Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease.
Ann Neurol
; 92(5): 729-744, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151869
6.
Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-ß monoclonal antibodies in dominantly inherited Alzheimer's disease.
Eur J Nucl Med Mol Imaging
; 50(9): 2669-2682, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37017737
7.
Learning slopes in early-onset Alzheimer's disease.
Alzheimers Dement
; 19 Suppl 9: S19-S28, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243937
8.
The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) Cohort.
Alzheimers Dement
; 19 Suppl 9: S74-S88, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850549
9.
Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort.
Alzheimers Dement
; 19 Suppl 9: S42-S48, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37296082
10.
Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection.
Alzheimers Dement
; 19 Suppl 9: S8-S18, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37256497
11.
Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease.
Alzheimers Dement
; 19 Suppl 9: S49-S63, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37496307
12.
White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
Alzheimers Dement
; 19 Suppl 9: S89-S97, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491599
13.
Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study.
Alzheimers Dement
; 19 Suppl 9: S115-S125, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491668
14.
Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
Alzheimers Dement
; 19 Suppl 9: S98-S114, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37690109
15.
Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's disease.
Alzheimers Dement
; 19 Suppl 9: S29-S41, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37653686
16.
Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohort.
Alzheimers Dement
; 19 Suppl 9: S64-S73, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801072
17.
Wolframin is a novel regulator of tau pathology and neurodegeneration.
Acta Neuropathol
; 143(5): 547-569, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35389045
18.
Patterns of tau pathology identified with 18 F-MK-6240 PET imaging.
Alzheimers Dement
; 18(2): 272-282, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34057284
19.
Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease.
N Engl J Med
; 378(4): 321-330, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29365294
20.
Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study.
Alzheimers Dement
; 17(8): 1353-1364, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580742